Investor Presentaiton slide image

Investor Presentaiton

MAX P&L statement for the network Healthcare FY19 FY20 FY21 Figs in INR Cr Change Amount % NR Amount % NR Amount % NR over LY Gross revenue (inc. movement in unbilled) 3,920 4,356 3,881 (10.9%) Net revenue 3,599 100.0% 4,023 100.0% 3,629 100.0% (9.8%) Direct costs 1,566 43.5% 1,715 42.6% 1,508 41.6% (12.0%) Contribution 2,033 56.5% 2,308 57.4% 2,121 58.4% (8.1%) Indirect overheads 1,685 46.8% 1,719 42.7% 1,485 40.9% (13.6%) Operating EBITDA (post Ind AS-116) 348 9.7% 590 14.7% 636 17.5% 7.9% Loss on fair valuation of pre-merger holding of Radiant 196 5.4% under IND AS 103 Transaction cost 30 0.8% 43 1.1% 48 1.3% 10.8% ESOP (Equity settled scheme) 27 0.7% One time policy harmonization impact 5 0.1% Movement in fair value of contingent consideration 19 0.5% (3) (0.1%) 0.0% and amortisation of contract assets Reported EBITDA 299 8.3% 549 13.6% 359 9.9% (34.7%) Finance cost (net) 155 4.3% 215 5.3% 187 5.2% (12.9%) Depreciation and amortisation 186 5.2% 208 5.2% 216 6.0% 3.6% Profit before tax (42) (1.2%) 126 3.1% (45) (1.2%) Tax 18 Profit after tax (60) 0.5% (1.7%) (3) (0.1%) 50 1.4% 129 3.2% (95) (2.6%) Note: 2. 3. 1. The numbers for the previous period have been recasted and regrouped to match with the disclosure in the current period FY19 financials are pre-IND AS -116 unaudited numbers based on arithmetic total of line items appearing in the pre-merger P&L of Max Healthcare and Radiant Lifecare Operating EBITDA (pre Ind AS-116) stood at INR 548 Cr in FY20 and INR 601 Cr in FY21 27
View entire presentation